Robert M. Janosky
Corporate Officer/Principal chez SATSUMA PHARMACEUTICALS, INC.
Postes actifs de Robert M. Janosky
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SATSUMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 05/03/2020 | - |
Historique de carrière de Robert M. Janosky
Anciens postes connus de Robert M. Janosky
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| DURECT CORPORATION | Corporate Officer/Principal | 01/01/2016 | 01/03/2020 |
Formation de Robert M. Janosky
| University of Vermont | Undergraduate Degree |
| University of Rochester Simon Business School | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DURECT CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
Satsuma Pharmaceuticals, Inc.
 Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraines. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company was founded by John Kollins on June 21, 2016 and is headquartered in Durham, NC. | Health Technology |
- Bourse
- Insiders
- Robert M. Janosky
- Expérience
